Caricamento...
Potential biomarkers to follow the progression and treatment response of Huntington’s disease
Huntington’s disease (HD) is a rare genetic disease caused by expanded polyglutamine repeats in the huntingtin protein resulting in selective neuronal loss. Although genetic testing readily identifies those who will be affected, current pharmacological treatments do not prevent or slow down disease...
Salvato in:
| Pubblicato in: | J Exp Med |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Rockefeller University Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5110026/ https://ncbi.nlm.nih.gov/pubmed/27821553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20160776 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|